| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2005 | EP1569654A1 Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic |
| 09/07/2005 | EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| 09/07/2005 | EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections |
| 09/07/2005 | EP1569651A1 Tablet comprising efletirizine and pseudoephedrine |
| 09/07/2005 | EP1569650A1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 09/07/2005 | EP1569649A2 Use of heterocyclic amine-type compounds as neuroprotective agents |
| 09/07/2005 | EP1569648A1 Prodrugs for use a ophthalmic agents |
| 09/07/2005 | EP1569645A2 Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors |
| 09/07/2005 | EP1569644A2 Indolizine compounds |
| 09/07/2005 | EP1569643A2 Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome |
| 09/07/2005 | EP1569642A1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 09/07/2005 | EP1569641A2 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/07/2005 | EP1569636A2 Use of equol for treating androgen mediated diseases |
| 09/07/2005 | EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 09/07/2005 | EP1569634A2 Use of a pparalpha agonist and metformin for decreasing the serum triglycerides |
| 09/07/2005 | EP1569633A2 Ca ix-specific inhibitors |
| 09/07/2005 | EP1569632A1 Composition for the treatment of pain, especially for the treatment of articular pain |
| 09/07/2005 | EP1569631A1 A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
| 09/07/2005 | EP1569630A1 Methods for preventing phototoxic damage during photodynamic therapy |
| 09/07/2005 | EP1569629A1 Topical antiinflammatory preparations of g(g)-terpinene |
| 09/07/2005 | EP1569628A1 Novel use of lycopene |
| 09/07/2005 | EP1569627A2 Method of treating movement disorders using barbituric acid derivatives |
| 09/07/2005 | EP1569626A1 Pharmaceutical porous particles |
| 09/07/2005 | EP1569623A1 A topical nanoparticulate spironolactone formulation |
| 09/07/2005 | EP1569620A1 Nanoparticulate bioactive agents |
| 09/07/2005 | EP1569618A2 Methods and compositions for applying pharmacologic agents to the ear |
| 09/07/2005 | EP1569617A1 Water stabilized medicinal aerosol formulation related applications |
| 09/07/2005 | EP1569616A2 An exopolysaccharides delivery system for active molecules |
| 09/07/2005 | EP1569612A1 Novel topical use of bis-arylimidazo 1,2-a thiolane derivatives |
| 09/07/2005 | EP1569607A2 Tough polymers |
| 09/07/2005 | EP1569599A2 Methods of usig and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 09/07/2005 | EP1569596A1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 09/07/2005 | EP1569595A1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 09/07/2005 | EP1569516A2 Methods for inhibiting cancer and scar formation |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1492767B1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1455760B1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 09/07/2005 | EP1447094A9 Remedies for pruritus |
| 09/07/2005 | EP1439829B1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1405637B1 Remedies for amyotrophic lateral sclerosis (als) |
| 09/07/2005 | EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene |
| 09/07/2005 | EP1399434B1 Novel indole derivatives |
| 09/07/2005 | EP1379223A4 Dental formulation |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 09/07/2005 | EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines |
| 09/07/2005 | EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 09/07/2005 | EP1335740B1 Preparations having effect against allergic symptoms and their manufacturing method |
| 09/07/2005 | EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists |
| 09/07/2005 | EP1328519B1 Orally active salts with tyrosine kinase activity |
| 09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1299430B1 Process for preparing benzoxazin-4-one polymer conjugates |
| 09/07/2005 | EP1294369B1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE |
| 09/07/2005 | EP1289953B1 Serine protease inhibitors |
| 09/07/2005 | EP1282621B1 Vitronectin receptor antagonists |
| 09/07/2005 | EP1280801B1 Hydantoin-containing glucokinase activators |
| 09/07/2005 | EP1263420B1 Retinoid formulations for aerosolization and inhalation |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1246642B1 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 09/07/2005 | EP1214314B1 Aminopiperidine derivatives as antibacterials |
| 09/07/2005 | EP1196195B1 Use of a fatty acid derivate in nasogastric enteral formulations |
| 09/07/2005 | EP1192132B1 Serine protease inhibitors |
| 09/07/2005 | EP1191936B1 Production of polygalacturonides and their use as food additives |
| 09/07/2005 | EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 09/07/2005 | EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 09/07/2005 | EP1165087B1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/07/2005 | EP1140026B1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 09/07/2005 | EP1140016B1 Composition set and kit for use in intraocular surgery |
| 09/07/2005 | EP1104291B1 Pellets having a core coated with an antifungal and a polymer |
| 09/07/2005 | EP1089679B1 A device and method for the treatment of erectile dysfunction |
| 09/07/2005 | EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 09/07/2005 | EP1037634B1 Oral administration form comprising a proton pump inhibitor (e.g.pantoprazole) |
| 09/07/2005 | EP1027029A4 Improved personal care formulations |
| 09/07/2005 | EP1023308B1 Inhibitors of nucleoside metabolism |
| 09/07/2005 | EP0888310B1 Cinnoline derivatives and use as medicine |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |
| 09/07/2005 | EP0731694B2 Opioid formulations for treating pain |
| 09/07/2005 | CN1665933A Immunoconjugates for the treatment of tumours |
| 09/07/2005 | CN1665930A Expression systems for stem loop RNA molecule having RNAi effect |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665922A Medium for culturing autologous human progenitor stem cells and applications thereof |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665828A Novel substituted sulfamate anticonvulsant derivatives |
| 09/07/2005 | CN1665826A Ruthenium anticancer complexes |
| 09/07/2005 | CN1665824A Substituted aryl boronic acids, their preparation and their precursors |
| 09/07/2005 | CN1665823A Process for preparing 1, 2, 3, 9-tetrahydro-9-methyl-3-[2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665820A Therapeutic or preventive agent for nausea/vomiting |
| 09/07/2005 | CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 09/07/2005 | CN1665817A Process for preparing certain pyrrolotriazine compounds |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665812A Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |